Comparison of real-world clinical and economic outcomes in patients receiving oral anticoagulants: A retrospective claims analysis

Direct oral anticoagulants (DOACs) have become widely used for the prevention of stroke in nonvalvular atrial fibrillation (AF) and for the treatment of venous thromboembolism (VTE). Warfarin, the standard of care prior to DOACs, requires monitoring and dose adjustment to ensure patients remain appr...

Ausführliche Beschreibung